Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: A correlation with the levels of neuroactive steroids in the sciatic nerve

Experimental Neurology

Volumn 228, Issue 2, 2011, Pages 215-221

  Pesaresi, Marzia ^a   Giatti, Silvia ^a   Cavaletti, Guido ^b   Abbiati, Federico ^a   Calabrese, Donato ^a   Bianchi, Roberto ^c   Caruso, Donatella ^a   Garcia Segura, Luis Miguel ^d   Melcangi, Roberto C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d INSTITUTO CAJAL   (Spain)

Author keywords

Dehydroepiandrosterone; Diabetes; Dihydrotestosterone; Liquid chromatography tandem mass spectrometry; Neuroprotection; Neurosteroids; Peripheral nervous system; Streptozotocin; Testosterone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANDROSTANOLONE; MYELIN PROTEIN; PRASTERONE; REACTIVE OXYGEN METABOLITE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; ENZYME ACTIVITY; FEMALE; HEAT SENSITIVITY; MALE; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; SEX DIFFERENCE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FEMALE; MALE; NERVE FIBERS, MYELINATED; ORCHIECTOMY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SEX CHARACTERISTICS; STEROIDS;

EID: 79952690529     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.01.005     Document Type: Article

References (48)

1. Aaberg M.L., Burch D.M., Hud Z.R., Zacharias M.P. Gender differences in the onset of diabetic neuropathy. J. Diabetes Complications 2008, 22:83-87.
2. Albers J.W., Brown M.B., Sima A.A., Greene D.A. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996, 46:85-91.
3. Babichev V.N., Adamskaya E.I., Kuznetsova T.A., Shishkina I.V. Neuroendocrine control of the gonadotropic function of the hypophysis in experimental diabetes. Neurosci. Behav. Physiol. 1998, 28:1-7.
4. Basit A., Hydrie M.Z., Hakeem R., Ahmedani M.Y., Masood Q. Frequency of chronic complications of type II diabetes. J. Coll. Physicians Surg. Pak. 2004, 14:79-83.
5. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc. Natl Acad. Sci. USA 2004, 101:823-828.
6. Bianchi R., Marini P., Merlini S., Fabris M., Triban C., Mussini E., Fiori M.G. ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes 1988, 37:1340-1345.
7. Booya F., Bandarian F., Larijani B., Pajouhi M., Nooraei M., Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005, 5:24.
8. Brown M.J., Bird S.J., Watling S., Kaleta H., Hayes L., Eckert S., Foyt H.L. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diab. Care 2004, 27:1153-1159.
9. Burul-Bozkurt N., Pekiner C., Kelicen P. Diabetes alters aromatase enzyme levels in sciatic nerve and hippocampus tissues of rats. Cell. Mol. Neurobiol. 2010, 30:445-451.
10. Caruso D., Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Melcangi R.C. Effects of short- and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J. Neuroendocrinol. 2010, 22:1137-1147.
11. Caruso D., Scurati S., Maschi O., De Angelis L., Roglio I., Giatti S., Garcia-Segura L.M., Melcangi R.C. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem. Int. 2008, 52:560-568.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
13. Dobretsov M., Romanovsky D., Stimers J.R. Early diabetic neuropathy: triggers and mechanisms. World J. Gastroenterol. 2007, 13:175-191.
14. Doublier S., Lupia E., Catanuto P., Elliot S.J. Estrogens and progression of diabetic kidney damage 2011, Curr Diabetes Rev, 7, 28-34.
15. Durant S., Christeff N., Coulaud J., Nunez E.A., Dardenne M., Homo-Delarche F. Basal concentrations of various steroids in the nonobese diabetic (NOD) mouse and effect of immobilization stress. Autoimmunity 1998, 28:249-258.
16. Giatti S., Pesaresi M., Cavaletti G., Bianchi R., Carozzi V., Lombardi R., Maschi O., Lauria G., Garcia-Segura L.M., Caruso D., Melcangi R.C. Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy 2009, Neuroscience, 164, 520-529.
17. Ha H., Endou H. Lipid peroxidation in isolated rat nephron segments. Am. J. Physiol. 1992, 263:F201-F207.
18. Islamov R.R., Hendricks W.A., Jones R.J., Lyall G.J., Spanier N.S., Murashov A.K. 17Beta-estradiol stimulates regeneration of sciatic nerve in female mice. Brain Res. 2002, 943:283-286.
19. Joseph E.K., Levine J.D. Sexual dimorphism in the contribution of protein kinase C isoforms to nociception in the streptozotocin diabetic rat. Neuroscience 2003, 120:907-913.
20. Kiziltan M.E., Gunduz A., Kiziltan G., Akalin M.A., Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J. Neurol. Sci. 2007, 258:75-79.
21. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007, 144:1293-1304.
22. Liu S., Mauvais-Jarvis F. Minireview: estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology 2010, 151:859-864.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
24. Maser R.E., Steenkiste A.R., Dorman J.S., Nielsen V.K., Bass E.B., Manjoo Q., Drash A.L., Becker D.J., Kuller L.H., Greene D.A., et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989, 38:1456-1461.
25. Melcangi R.C., Garcia-Segura L.M. Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm. Behav. 2010, 57:2-11.
26. Melcangi R.C., Garcia-Segura L.M., Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 2008, 65:777-797.
27. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Caruso D., Melcangi R.C. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. 2010, 57:46-55.
28. Pisarev V.B., Snigur G.L., Spasov A.A., Samokhina M.P., Bulanov A.E. Mechanisms of toxic effect of streptozotocin on beta-cells in the islets of langerhans. Bull. Exp. Biol. Med. 2009, 148:937-939.
29. Roglio I., Bianchi R., Camozzi F., Carozzi V., Cervellini I., Crippa D., Lauria G., Cavaletti G., Melcangi R.C. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. J. Peripher. Nerv. Syst. 2009, 14:36-44.
30. Roglio I., Bianchi R., Giatti S., Cavaletti G., Caruso D., Scurati S., Crippa D., Garcia-Segura L.M., Camozzi F., Lauria G., Melcangi R.C. Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell. Mol. Life Sci. 2007, 64:1158-1168.
31. Roglio I., Bianchi R., Gotti S., Scurati S., Giatti S., Pesaresi M., Caruso D., Panzica G.C., Melcangi R.C. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 2008, 155:673-685.
32. Roglio I., Giatti S., Pesaresi M., Bianchi R., Cavaletti G., Lauria G., Garcia-Segura L.M., Melcangi R.C. Neuroactive steroids and peripheral neuropathy. Brain Res. Rev. 2008, 57:460-469.
33. Said G. Diabetic neuropathy-a review. Nat. Clin. Pract. Neurol. 2007, 3:331-340.
34. Salonia A., Lanzi R., Scavini M., Pontillo M., Gatti E., Petrella G., Licata G., Nappi R.E., Bosi E., Briganti A., Rigatti P., Montorsi F. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diab. Care 2006, 29:312-316.
35. Saravia F., Revsin Y., Lux-Lantos V., Beauquis J., Homo-Delarche F., De Nicola A.F. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J. Neuroendocrinol. 2004, 16:704-710.
36. Saravia F.E., Beauquis J., Revsin Y., Homo-Delarche F., de Kloet E.R., De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell. Mol. Neurobiol. 2006, 26:943-957.
37. Sima A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci. 2003, 60:2445-2464.
38. Suter U., Scherer S.S. Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 2003, 4:714-726.
39. Szalat A., Raz I. Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes. Metab. 2008, 10:1135-1156.
40. Tanaka M., Nakaya S., Kumai T., Watanabe M., Matsumoto N., Kobayashi S. Impaired testicular function in rats with diet-induced hypercholesterolemia and/or streptozotocin-induced diabetes mellitus. Endocr. Res. 2001, 27:109-117.
41. Tomlinson D.R., Gardiner N.J. Diabetic neuropathies: components of etiology. J. Peripher. Nerv. Syst. 2008, 13:112-121.
42. Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J. Neurooncol. 1998, 36:31-40.
43. van Dam E.W., Dekker J.M., Lentjes E.G., Romijn F.P., Smulders Y.M., Post W.J., Romijn J.A., Krans H.M. Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diab. Care 2003, 26:1812-1818.
44. van Dam P.S. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. 2002, 18:176-184.
45. Veiga S., Leonelli E., Beelke M., Garcia-Segura L.M., Melcangi R.C. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci. Lett. 2006, 402:150-153.
46. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25:612-628.
47. Yamabe N., Kang K.S., Zhu B.T. Beneficial effect of 17beta-estradiol on hyperglycemia and islet beta-cell functions in a streptozotocin-induced diabetic rat model. Toxicol. Appl. Pharmacol. 2010, 249:76-85.
48. Yorek M.A., Coppey L.J., Gellett J.S., Davidson E.P., Bing X., Lund D.D., Dillon J.S. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E1067-E1075.